ruthenium has been researched along with Thyroid Carcinoma, Anaplastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allegri, L; Baldan, F; Ballico, M; Baratta, W; Damante, G; Jandl, C; Lovison, D | 1 |
1 other study(ies) available for ruthenium and Thyroid Carcinoma, Anaplastic
| Article | Year |
|---|---|
Cationic carboxylate and thioacetate ruthenium(ii) complexes: synthesis and cytotoxic activity against anaplastic thyroid cancer cells.
Topics: Antineoplastic Agents; Carboxylic Acids; Cations; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coordination Complexes; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Ruthenium; Structure-Activity Relationship; Sulfhydryl Compounds; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms | 2020 |